Oliver Keil

A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium

Ansgar Santel, Manuela Aleku, Oliver Keil et al. · Gene Therapy · 2006 · 365 citations

Engineering, Rna Interference, Medicine +11

Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression

Manuela Aleku, Petra Schulz, Oliver Keil et al. · Cancer Research · 2008 · 294 citations · Full text

First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors

Beate Schultheis, Dirk Strumberg, Ansgar Santel et al. · Journal of Clinical Oncology · 2014 · 250 citations

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy

Ansgar Santel, Manuela Aleku, Oliver Keil et al. · Gene Therapy · 2006 · 184 citations

Angiogenesis, Rna Interference, Systemic Administration +11

Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors

Dirk Strumberg, Beate Schultheis, U. Traugott et al. · International Journal of Clinical Pharmacology and Therapeutics · 2011 · 135 citations

Nanotherapeutics, Engineering, Advanced Solid Tumors +22